Abstract
This study assessed pediatric invasive pneumococcal disease (IPD) post-COVID-19. No cases appeared in the first two pandemic years, but 12 were diagnosed after 2022. Identified serotypes included 3, 6B, 19, and untypeable G. Despite PCV13, infections persist, especially serotype 3, notable for its robust capsule.